HCPCS C9098

Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Retired code0 hospitals with prices

Description from CMS's HCPCS Level II code file.

This code is retired. Some hospitals still list it.

What Washington hospitals publish for this code

No Washington hospital publishes a dollar price for this code yet.

Medicare (traditional) reference

CMS publishes no national amount for this code.